Hawaii in $700 million settlement with Bristol-Myers, Sanofi over Plavix warning label
ReutersMay 10, 2025 12:20 AM
May 9 (Reuters) - Hawaii said on Friday it entered a $700 million settlement deal with pharmaceutical firm Bristol-Myers Squibb BMY.N and units of French pharmaceutical company Sanofi SASY.PA in a case about warning labels related to health risks from blood thinner Plavix.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Meta’s Big Bet: Soaring Profits, Sky-High Risks
TradingKey - Meta's (META) Q1 2025 earnings come in with the world watching in scrutiny. The company has established itself as a platform that exists at the intersection of AI infrastructure, hardware innovation, and next-wave advertising.TradingKey
Fri, May 9
Understanding the U.S. Fiscal Framework: Is Trump’s Tariff-for-Tax-Cut Strategy Viable?
TradingKey – With the U.S. Senate and House of Representatives passing the budget resolution for President Donald Trump's second administration (Trump 2.0), his fiscal blueprint—centered on tax cuts, slashing government spending, and debt reduction—is moving forward. However, with federal debt at...TradingKey
Fri, May 9
[IN-DEPTH ANALYSIS] Eurozone: EUR/USD Short-Term Outlook – One Word "Rise"; Two Words "Keep Rising"; Three Words "Continue to Rise"
TradingKey - In the short term (0-3 months), the EUR/USD exchange rate is expected to rise, primarily driven by developments on the USD side.TradingKey
Tue, May 6
TSMC 2025 Q1 Outlook: AI-Driven Growth and Supply Chain Breakthrough Amid Tariff Pressures
As the world's leading semiconductor foundry, TSMC's Q1 2025 revenue reached NT$839.254 billion, a year-on-year increase of 41.6%, exceeding market expectations and in line with the company's guidance of NT$820 billion to NT$846.24 billion.TradingKey
Tue, Apr 15
